Abbott Laboratories (ABT)
117.71
+0.06
(+0.05%)
USD |
NYSE |
Nov 05, 16:00
118.00
+0.29
(+0.25%)
After-Hours: 19:10
Abbott Laboratories Research and Development Expense (Annual): 2.741B for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.741B |
| December 31, 2022 | 2.888B |
| December 31, 2021 | 2.742B |
| December 31, 2020 | 2.42B |
| December 31, 2019 | 2.44B |
| December 31, 2018 | 2.30B |
| December 31, 2017 | 2.26B |
| December 31, 2016 | 1.447B |
| December 31, 2015 | 1.405B |
| December 31, 2014 | 1.345B |
| December 31, 2013 | 1.371B |
| December 31, 2012 | 1.461B |
| December 31, 2011 | 1.512B |
| December 31, 2010 | 3.724B |
| December 31, 2009 | 2.914B |
| December 31, 2008 | 2.689B |
| Date | Value |
|---|---|
| December 31, 2007 | 2.506B |
| December 31, 2006 | 2.255B |
| December 31, 2005 | 1.821B |
| December 31, 2004 | 1.697B |
| December 31, 2003 | 1.624B |
| December 31, 2002 | 1.475B |
| December 31, 2001 | 1.578B |
| December 31, 2000 | 1.351B |
| December 31, 1999 | 1.194B |
| December 31, 1998 | 1.229B |
| December 31, 1997 | 1.307B |
| December 31, 1996 | 1.205B |
| December 31, 1995 | 1.073B |
| December 31, 1994 | 963.52M |
| December 31, 1993 | 880.97M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
2.42B
Minimum
2020
2.888B
Maximum
2022
2.646B
Average
2.741B
Median
2023
Research and Development Expense (Annual) Benchmarks
| Boston Scientific Corp | 1.414B |
| Becton Dickinson & Co | 1.237B |
| ResMed Inc | 307.52M |
| Integra Lifesciences Holdings Corp | 104.19M |
| QuidelOrtho Corp | 246.80M |